Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|November 22, 2017
[Systemic therapy for advanced endometrial cancer]Patricia Pautier, Fanny Pommeret
Expert Review of Anticancer Therapy|April 13, 2019
Rucaparib in the landscape of PARP inhibition in ovarian cancerEmeline Colomba, Patricia Pautier, Fanny Pommeret, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 22, 2022
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric studyMarc Hilmi, Natacha Naoun, Alice Boilève, et al.
Gynecologic Oncology|October 16, 2020
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registryJudith Michels, Catherine Genestie, Ariane Dunant, et al.
British Journal of Cancer|March 23, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomesHervé Bonnefoi, Gaetan MacGrogan, Coralie Poncet, et al.
The Lancet. Healthy Longevity|September 13, 2022
Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 studyClaire Falandry, Fanny Pommeret, Laurence Gladieff, et al.
Journal of Proteome Research|October 1, 2024
Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19Jean-Marie Michot, Vito Dozio, Julien Rohmer, et al.
Gynecologic Oncology|July 28, 2022
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ studyFlorence Joly, Michel Fabbro, Dominique Berton, et al.
Nature Cancer|February 5, 2022
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albiges, Stéphanie Foulon, Arnaud Bayle, et al.
BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.
Pageof 3